Treatment of West Nile Virus With MGAWN1

NCT00927953 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

INDUSTRY

Sponsor class

Stopped Early termination due to the inability to enroll (13 of 120 subjects enrolled)

Conditions

West Nile Neuroinvasive Disease
West Nile Virus Infection
Encephalitis
Meningitis
Acute Flaccid Paralysis
West Nile Fever

Interventions

BIOLOGICAL: MGAWN1
BIOLOGICAL: Placebo - normal saline

Sponsor

MacroGenics

Collaborators

[object Object]